These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33311741)

  • 1. COVID-19 Testing Tests Our Mettle.
    Hefferon KL; St Juliana JR; Miller HI
    Mo Med; 2020; 117(5):417-420. PubMed ID: 33311741
    [No Abstract]   [Full Text] [Related]  

  • 2. Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    Kivelä JM; Jarva H; Lappalainen M; Kurkela S
    J Med Virol; 2021 Mar; 93(3):1256-1258. PubMed ID: 33079392
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-testing for SARS-CoV-2: importance of lay communication.
    Coste AT; Egli A; Greub G
    Swiss Med Wkly; 2021 May; 151():w20526. PubMed ID: 34101820
    [No Abstract]   [Full Text] [Related]  

  • 4. Fortifying the diagnostic-frontiers with nanoscale technology amidst the COVID-19 catastrophe.
    Konwarh R; Cho WC
    Expert Rev Mol Diagn; 2021 Feb; 21(2):131-135. PubMed ID: 33470125
    [No Abstract]   [Full Text] [Related]  

  • 5. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 antibody tests: statistical implications.
    Kankam HK; Hourston GJ; Ravindran P; Azhar B; Pope C
    Br J Hosp Med (Lond); 2020 Nov; 81(11):1-5. PubMed ID: 33263485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid coronavirus tests: a guide for the perplexed.
    Guglielmi G
    Nature; 2021 Feb; 590(7845):202-205. PubMed ID: 33564189
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroreactivity with COVID-19 antibody testing in CCP donors presenting without a SARS-CoV-2 diagnostic test.
    Goodhue Meyer EK; Xu M; Lasky B; Young PP
    Transfusion; 2021 Jan; 61(1):330-331. PubMed ID: 33037643
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M
    J Virol Methods; 2021 Feb; 288():114024. PubMed ID: 33227341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-Care SARS-CoV-2 Variant Diagnostic in Development.
    Abbasi J
    JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519815
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 diagnostics: Some reflections on current assays.
    Antonelli G; Stefani S; Pistello M
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115237. PubMed ID: 33130508
    [No Abstract]   [Full Text] [Related]  

  • 13. The COVID-19 Pandemic and
    Moy L; Bluemke DA
    Radiology; 2021 Mar; 298(3):483-484. PubMed ID: 33434114
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacist's role in SARS-CoV-2 diagnostic testing.
    Goode JR; Page A; Burns A; Bernard S; Wheawill S; Gatewood SBS
    J Am Pharm Assoc (2003); 2020; 60(6):e19-e32. PubMed ID: 32883622
    [No Abstract]   [Full Text] [Related]  

  • 15. What two US counties will tell us about COVID-19.
    Nat Biotechnol; 2021 May; 39(5):533. PubMed ID: 33981080
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 testing processes and patient protections for resumption of elective surgery.
    Schlosser M; Signorelli H; Gregg W; Korwek K; Sands K
    Am J Surg; 2021 Jan; 221(1):49-52. PubMed ID: 32736801
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined Self-Collected Anterior Nasal and Oropharyngeal Specimens versus Provider-Collected Nasopharyngeal Swabs for the Detection of SARS-CoV-2.
    Shakir SM; Barker AP; Hillyard DR; Gilmore N; Barrett JW; Orlandi RR; Hanson KE
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087437
    [No Abstract]   [Full Text] [Related]  

  • 18. Interpreting SARS-CoV-2 Test Results.
    Coffey KC; Diekema DJ; Morgan DJ
    JAMA; 2021 Oct; 326(15):1528-1529. PubMed ID: 34533581
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostics in the Time of Coronavirus Disease 2019 (COVID-19): Challenges and Opportunities.
    Zehnbauer B
    J Mol Diagn; 2021 Jan; 23(1):1-2. PubMed ID: 33349346
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of 4 molecular assays for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Uprety P; Mathew J; Weinstein MP; Kirn TJ
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115196. PubMed ID: 33220615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.